N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats. (Q46017960)

18 December 2017

http://europepmc.org/abstract/MED/24000072

title

N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats. (English)

1 reference

18 December 2017

http://europepmc.org/abstract/MED/24000072

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

Brian Harvey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

Marisa Möller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

Jan du Preez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Francois P Viljoen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

publication date

3 September 2013

1 reference

18 December 2017

http://europepmc.org/abstract/MED/24000072

published in

Metabolic Brain Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

687-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000072 AND SRC:MED&resulttype=core&format=json

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Activation of ATP-sensitive K (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The promise of N-acetylcysteine in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The importance of serotonin and noradrenaline in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The development of anxiety: The role of control in the early environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Inflammation-associated depression: from serotonin to kynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Mitochondrial diseases mimicking neurotransmitter defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Low levels of MHPG in depressive spectrum patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Neurobiology of dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Oxidative stress in anxiety and comorbid disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The possible involvement of metabotropic glutamate receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Mechanisms of adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Neuroplasticity of neocortical circuits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetylcysteine for major depressive episodes in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Non-synaptic release of [3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Impaired antioxidant defense at the onset of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Stress, glucocorticoids and glutamate release: Effects of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Biology of post-traumatic stress disorder in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Glutamate neurocircuitry: theoretical underpinnings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Redox mechanisms at the glutamate synapse and their significance: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Proposal for a noradrenaline hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-013-9433-Z

Glutathione metabolism and its implications for health

21 January 2018

1 reference

12 December 2020

Changes in basal and stimulated release of endogenous serotonin from different nuclei of rats subjected to two models of depression

1 reference

12 December 2020

Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury

1 reference

12 December 2020

Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.

1 reference

12 December 2020

Neurochemical differences in two rat strains exposed to social isolation rearing.

1 reference

12 December 2020

Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration

1 reference

12 December 2020

Hypofrontality and negative symptoms in major depressive disorder

1 reference

12 December 2020

Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development

1 reference

12 December 2020

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

1 reference

12 December 2020